Stable aqueous formulations of adalimumab Patent Grant Manning , et al. Sept [Coherus Biosciences, Inc.]

Por um escritor misterioso
Last updated 27 março 2025
Stable aqueous formulations of adalimumab Patent Grant Manning , et al.  Sept [Coherus Biosciences, Inc.]
U.S. Patent Number 10780163 for Stable aqueous formulations of adalimumab
Stable aqueous formulations of adalimumab Patent Grant Manning , et al.  Sept [Coherus Biosciences, Inc.]
WO2014039903A2 - Stable aqueous formulations of adalimumab
Stable aqueous formulations of adalimumab Patent Grant Manning , et al.  Sept [Coherus Biosciences, Inc.]
US9114166B2 - Formulation of human antibodies for treating TNF-α
Stable aqueous formulations of adalimumab Patent Grant Manning , et al.  Sept [Coherus Biosciences, Inc.]
EP3351269B1 - Self-buffering protein formulations - Google Patents
Stable aqueous formulations of adalimumab Patent Grant Manning , et al.  Sept [Coherus Biosciences, Inc.]
US9505833B2 - Human antibodies that bind human TNF-alpha and
Stable aqueous formulations of adalimumab Patent Grant Manning , et al.  Sept [Coherus Biosciences, Inc.]
US20150190513A1 - Stable Aqueous Formulations of Adalimumab
Stable aqueous formulations of adalimumab Patent Grant Manning , et al.  Sept [Coherus Biosciences, Inc.]
WO2014039903A2 - Stable aqueous formulations of adalimumab
Stable aqueous formulations of adalimumab Patent Grant Manning , et al.  Sept [Coherus Biosciences, Inc.]
WO2014039903A2 - Stable aqueous formulations of adalimumab
Stable aqueous formulations of adalimumab Patent Grant Manning , et al.  Sept [Coherus Biosciences, Inc.]
US9290568B2 - Methods to control protein heterogeneity - Google
Stable aqueous formulations of adalimumab Patent Grant Manning , et al.  Sept [Coherus Biosciences, Inc.]
US9522953B2 - Low acidic species compositions and methods for
Stable aqueous formulations of adalimumab Patent Grant Manning , et al.  Sept [Coherus Biosciences, Inc.]
US20180311350A1 - Stable aqueous formulations of adalimumab

© 2014-2025 praharacademy.in. All rights reserved.